Controlled Substances Regulations (SOR/2025-242)

Marginal note:Sale to practitioner

• The following provision is not in force.

  94 (1) A pharmacist may sell or provide a controlled substance, other than a restricted drug, to a practitioner if they first receive from the practitioner a written order that is signed and dated and that contains the following information or, in the case of an emergency, either such a written order or a verbal order:

  • The following provision is not in force.

    (a) with respect to the practitioner, their name and the name and municipal address of the place where they practise;

  • The following provision is not in force.

    (b) with respect to the pharmacist, their name and the name and municipal address of the place where they practise;

  • The following provision is not in force.

    (c) the date of the order;

  • The following provision is not in force.

    (d) in the case of a controlled substance set out in any of Schedules 1 to 3, its name, form and quantity; and

  • The following provision is not in force.

    (e) in the case of a finished product,

    • (i) its name or, if applicable, brand name, as well as the name of the controlled substance it contains,

    • (ii) its form, its strength, the number of containers and, if applicable, the number of units per container, and

    • (iii) its drug identification number, if any.

• The following provision is not in force.

  Marginal note:Exception — prohibition

  (2) A pharmacist must not sell or provide to the practitioner a controlled substance that is the subject of a prohibition on the practitioner’s professional practice imposed by the provincial professional regulatory authority.

Marginal note:Sale to hospital

95 A pharmacist may sell or provide a controlled substance, other than a restricted drug, to a hospital if they first receive from the hospital a written order that is signed and dated by a person permitted to place an order on the hospital’s behalf and that contains the following information or, in the case of an emergency, either such a written order or a verbal order from such a person:

• The following provision is not in force.

  (a) with respect to the hospital, its name and municipal address, as well as the name and title of the person placing the order;

• The following provision is not in force.

  (b) with respect to the pharmacist, their name and the name and municipal address of the place where they practise;

• The following provision is not in force.

  (c) the date of the order;

• The following provision is not in force.

  (d) in the case of a controlled substance set out in any of Schedules 1 to 3, its name, form and quantity; and

• The following provision is not in force.

  (e) in the case of a finished product,

  • (i) its name or, if applicable, brand name, as well as the name of the controlled substance it contains,

  • (ii) its form, its strength, the number of containers and, if applicable, the number of units per container, and

  • (iii) its drug identification number, if any.

Marginal note:Sale to exempted person

96 A pharmacist may sell or provide a controlled substance, other than a restricted drug, to a person exempted under subsection 56(1) of the Act with respect to that controlled substance if

• The following provision is not in force.

  (a) the pharmacist first receives from the exempted person a copy of the exemption;

• The following provision is not in force.

  (b) there are terms and conditions for the sale or provision by the pharmacist that are specified in the exemption; and

• The following provision is not in force.

  (c) the sale or provision is carried out in accordance with those terms and conditions.

Marginal note:Sale to Minister

97 A pharmacist may sell or provide a controlled substance to the Minister if they first receive from the Minister a written order that is signed and dated on the Minister’s behalf and that contains the following information:

• The following provision is not in force.

  (a) with respect to the individual signing the order, their name and, if applicable, title, as well as the municipal address of the place where the controlled substance is to be delivered, sent or transported;

• The following provision is not in force.

  (b) with respect to the pharmacist, their name and the name and municipal address of the place where they practise;

• The following provision is not in force.

  (c) the date of the order;

• The following provision is not in force.

  (d) in the case of a controlled substance set out in any of Schedules 1 to 3, its name, form and quantity; and

• The following provision is not in force.

  (e) in the case of a finished product,

  • (i) its name or, if applicable, brand name, as well as the name of the controlled substance it contains,

  • (ii) its form, its strength, the number of containers and, if applicable, the number of units per container, and

  • (iii) its drug identification number, if any.

Marginal note:Sale to individual

• The following provision is not in force.

  98 (1) A pharmacist may sell or provide a controlled substance to an individual if

  • The following provision is not in force.

    (a) the sale or provision is for the individual’s own use, for the use of another individual or for an animal;

  • The following provision is not in force.

    (b) the controlled substance is in the form of a finished product that does not contain a restricted drug; and

  • The following provision is not in force.

    (c) subject to subsection (2), the pharmacist first receives the following in respect of the controlled substance from one of the following persons:

    • (i) in the case of the individual, a written prescription,

    • (ii) in the case of another pharmacist or a pharmacy technician,

      • (A) a written prescription, or

      • (B) a copy of the document on which the information with respect to a verbal prescription has been recorded under section 117, or

    • (iii) in the case of a practitioner, a written or verbal prescription.

• The following provision is not in force.

  Marginal note:Finished product containing low dose of codeine

  (2) A pharmacist may sell or provide, without a prescription, a finished product containing codeine phosphate to an individual if

  • The following provision is not in force.

    (a) the finished product contains

    • (i) in the case of a finished product in solid form, not more than 8 mg or its equivalent of codeine phosphate per unit, or

    • (ii) in the case of a finished product in liquid form, not more than 20 mg or its equivalent of codeine phosphate per 30 mL;

  • The following provision is not in force.

    (b) the finished product contains

    • (i) two additional medicinal ingredients other than a narcotic in a quantity of not less than the regular minimum single dose for one such ingredient or one-half of the regular minimum single dose for each such ingredient, or

    • (ii) three additional medicinal ingredients other than a narcotic in a quantity of not less than the regular minimum single dose for one such ingredient or one-third of the regular minimum single dose for each such ingredient;

  • The following provision is not in force.

    (c) the pharmacist has reasonable grounds to believe that the finished product will only be used for recognized medical purposes; and

  • The following provision is not in force.

    (d) the pharmacist ensures that the following caution or its equivalent is conspicuously and legibly printed on the finished product’s inner label and outer label, as those terms are defined in section A.01.010 of the Food and Drug Regulations:

  The following provision is not in force.

  “This product contains codeine and should not be administered to children except on the advice of a physician, dentist or nurse practitioner.”

Marginal note:Orders and prescriptions

• The following provision is not in force.

  99 (1) A pharmacist or pharmacy technician may compound a finished product, other than one containing a restricted drug, if they do so for the purpose of fulfilling a prescription and if they first receive the following with respect to the finished product from one of the following persons:

  • The following provision is not in force.

    (a) in the case of an individual, a written prescription;

  • The following provision is not in force.

    (b) in the case of another pharmacist,

    • (i) a written order that is signed and dated and that contains the information set out in subsection (2) or, in the case of an emergency, either such a written order or a verbal order,

    • (ii) a written prescription, or

    • (iii) a copy of the document on which the information with respect to a verbal prescription is recorded under section 117;

  • The following provision is not in force.

    (c) in the case of another pharmacy technician,

    • (i) a written prescription, or

    • (ii) a copy of the document on which the information with respect to a verbal prescription is recorded under section 117;

  • The following provision is not in force.

    (d) in the case of a practitioner,

    • (i) if they are not practising in a hospital, a written order that is signed and dated and that contains the information set out in subsection (2) or, in the case of an emergency, either such a written order or a verbal order, or

    • (ii) a written or verbal prescription; or

  • The following provision is not in force.

    (e) in the case of a hospital, a written order that is signed and dated by a person permitted to place an order on the hospital’s behalf and that contains the information set out in subsection (2) or, in the case of an emergency, either such a written order or a verbal order from such a person.

• The following provision is not in force.

  Marginal note:Written orders

  (2) The information that must be contained in the written order is the following:

  • The following provision is not in force.

    (a) with respect to the person placing the order,

    • (i) in the case of another pharmacist, their name and the name and municipal address of the place where they practise,

    • (ii) in the case of a practitioner, their name and the name and municipal address of the place where they practise, and

    • (iii) in the case of a hospital, its name and municipal address, as well as the name of the person permitted to place the order on its behalf;

  • The following provision is not in force.

    (b) with respect to the pharmacist or pharmacy technician compounding the finished product, their name and the name and municipal address of the place where they practise;

  • The following provision is not in force.

    (c) the date of the order;

  • The following provision is not in force.

    (d) with respect to the finished product,

    • (i) its name, and

    • (ii) its form, strength, the number of containers and, if applicable, the number of units per container; and

  • The following provision is not in force.

    (e) if applicable, a declaration from the other pharmacist that they require the finished product for emergency purposes.

Marginal note:Sale and compounding

100 A pharmacist who sells or provides a controlled substance or who compounds a finished product may, before the sale, provision or compounding, substitute a controlled substance for another controlled substance identified in a prescription, if the pharmacist is authorized to do so under the laws of the province where the sale, provision or compounding takes place.

Marginal note:Extension of prescription

101 A pharmacist may extend a prescription if the new expiration date of the extended prescription is not later than two years after the day on which the pharmacist received the prescription.

Marginal note:Transfer of prescription

102 A pharmacist or pharmacy technician may transfer a prescription to another pharmacist or pharmacy technician if

• The following provision is not in force.

  (a) they transfer it within two years after the day on which the prescription was received; and

• The following provision is not in force.

  (b) they provide

  • (i) in the case of a controlled substance prescribed in writing, the written prescription, or

  • (ii) in the case of a controlled substance prescribed verbally, a copy of the document on which the information with respect to that verbal prescription is recorded under section 117.

Marginal note:Orders and prescriptions

103 A pharmacist or pharmacy technician who receives an order or prescription from a person for a controlled substance must verify the person’s name and, if applicable, their title as well as their signature if it is not known to the pharmacist.

Marginal note:Receipt of substance from individual

104 A pharmacist or pharmacy technician who receives a controlled substance from an individual for the purposes of destruction must keep the substance in a collection container that is in a secure location to which only persons whom the pharmacist or technician has authorized have access and that is marked in a manner that is sufficient to identify the container.

Marginal note:Authorized access

105 A pharmacist must ensure that

• The following provision is not in force.

  (a) any controlled substance is stored in a secure location at the place where they practise; and

• The following provision is not in force.

  (b) only persons whom the pharmacist has authorized have access to that secure location.